Unlock stock picks and a broker-level newsfeed that powers Wall Street. Upgrade Now
Canadian Sec - Delayed Quote CAD

Ovation Science Inc. (OVAT.CN)

Compare
0.0250
0.0000
(0.00%)
At close: February 19 at 1:09:45 PM EST
Loading Chart for OVAT.CN
  • Previous Close 0.0250
  • Open 0.0000
  • Bid --
  • Ask --
  • Day's Range 0.0000 - 0.0000
  • 52 Week Range 0.0000 - 0.0550
  • Volume 0
  • Avg. Volume 3,618
  • Market Cap (intraday) 946,117
  • Beta (5Y Monthly) 0.36
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0200
  • Earnings Date --
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Ovation Science Inc. engages in the production, sub-licensing, and sale of cannabis or hemp products in Canada and the United States. The company sublicenses product formulations through Invisicare, a patented drug delivery technology to produce topical and transdermal cannabis products under the Ovation name. It also offers cannabidiol health and wellness solutions under the Invibe MD name; skincare solutions under the ARLO CBD name; and topical and transdermal creams and lotions with CBD, THC, and combinations, as well as hemp seed oil. Ovation Science Inc. was incorporated in 2017 and is headquartered in Vancouver, Canada. Ovation Science Inc. operates as a subsidiary of Skinvisible Pharmaceuticals, Inc.

ovationscience.com

--

Full Time Employees

December 31

Fiscal Year Ends

Recent News: OVAT.CN

View More

Performance Overview: OVAT.CN

Trailing total returns as of 3/10/2025, which may include dividends or other distributions. Benchmark is S&P/TSX Composite index .

YTD Return

OVAT.CN
0.00%
S&P/TSX Composite index
0.97%

1-Year Return

OVAT.CN
50.00%
S&P/TSX Composite index
12.16%

3-Year Return

OVAT.CN
58.33%
S&P/TSX Composite index
13.43%

5-Year Return

OVAT.CN
92.86%
S&P/TSX Composite index
62.99%

Compare To: OVAT.CN

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: OVAT.CN

View More

Valuation Measures

Annual
As of 3/7/2025
  • Market Cap

    946.12k

  • Enterprise Value

    1.20M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    7.70

  • Price/Book (mrq)

    --

  • Enterprise Value/Revenue

    10.68

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -387.12%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    111.95k

  • Net Income Avi to Common (ttm)

    -641.09k

  • Diluted EPS (ttm)

    -0.0200

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    9.96k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    -143.39k

Research Analysis: OVAT.CN

View More

Company Insights: OVAT.CN

Research Reports: OVAT.CN

View More

People Also Watch